SCHEMBL22025479

SCHEMBL22025479

BC(=O)/C=C/[C@H]1CC(F)(F)C(=O)N1I

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 1/20 0.31
▸ PTGER3 P43115 1/20 0.31
▸ PTGER2 P43116 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18133252 0.81 PTGER4 (0.35) PTGER4PTGER3PTGER2
SCHEMBL18943211 0.74 NOTUM (0.30) —
SCHEMBL18943066 0.70 — —
SCHEMBL18948464 0.69 PTGER4 (0.31) PTGER4PTGER2
SCHEMBL22024924 0.64 NOTUM (0.33) —
SCHEMBL22025629 0.63 NOTUM (0.32) —
SCHEMBL18943079 0.62 APLNR (0.31) —
SCHEMBL16408740 0.58 PTGER4 (0.41) PTGER4PTGER3PTGER2
SCHEMBL17808005 0.54 PTGER4 (0.38) PTGER4PTGER3PTGER2
SCHEMBL19588832 0.52 P2RX7 (0.42) PTGER4PTGER3PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176162-B1 DIFLUOROLACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASE AND CONDITIONS CAYMAN CHEMICAL CO INC (US) 2020-05-27 — — EP disclosed
Send feedback